nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—Lamivudine—hepatitis B	0.464	1	CrCtD
Zalcitabine—Didanosine—Entecavir—hepatitis B	0.138	0.414	CrCrCtD
Zalcitabine—DCK—Lamivudine—hepatitis B	0.101	0.682	CbGbCtD
Zalcitabine—Emtricitabine—Lamivudine—hepatitis B	0.0602	0.18	CrCrCtD
Zalcitabine—Gemcitabine—Lamivudine—hepatitis B	0.0504	0.151	CrCrCtD
Zalcitabine—SLC22A6—Adefovir Dipivoxil—hepatitis B	0.0297	0.201	CbGbCtD
Zalcitabine—Decitabine—Entecavir—hepatitis B	0.025	0.0747	CrCrCtD
Zalcitabine—Cytarabine—Lamivudine—hepatitis B	0.0209	0.0625	CrCrCtD
Zalcitabine—Decitabine—Telbivudine—hepatitis B	0.0207	0.0619	CrCrCtD
Zalcitabine—Decitabine—Lamivudine—hepatitis B	0.0189	0.0566	CrCrCtD
Zalcitabine—SLC22A6—Lamivudine—hepatitis B	0.0174	0.118	CbGbCtD
Zalcitabine—Lactic acidosis—Entecavir—hepatitis B	0.00184	0.039	CcSEcCtD
Zalcitabine—Lactic acidosis—Telbivudine—hepatitis B	0.00151	0.032	CcSEcCtD
Zalcitabine—Sinus headache—Telbivudine—hepatitis B	0.00113	0.024	CcSEcCtD
Zalcitabine—Fat redistribution—Lamivudine—hepatitis B	0.00108	0.023	CcSEcCtD
Zalcitabine—Musculoskeletal chest pain—Telbivudine—hepatitis B	0.000951	0.0202	CcSEcCtD
Zalcitabine—Flank pain—Telbivudine—hepatitis B	0.000915	0.0194	CcSEcCtD
Zalcitabine—Kidney function abnormal—Adefovir Dipivoxil—hepatitis B	0.000906	0.0192	CcSEcCtD
Zalcitabine—Lactic acidosis—Lamivudine—hepatitis B	0.000851	0.018	CcSEcCtD
Zalcitabine—Nephropathy toxic—Adefovir Dipivoxil—hepatitis B	0.000762	0.0162	CcSEcCtD
Zalcitabine—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.000753	0.016	CcSEcCtD
Zalcitabine—Myositis—Telbivudine—hepatitis B	0.000752	0.0159	CcSEcCtD
Zalcitabine—Loose stools—Telbivudine—hepatitis B	0.000666	0.0141	CcSEcCtD
Zalcitabine—Hepatomegaly—Entecavir—hepatitis B	0.000634	0.0134	CcSEcCtD
Zalcitabine—Myopathy—Adefovir Dipivoxil—hepatitis B	0.000624	0.0132	CcSEcCtD
Zalcitabine—Glycosuria—Entecavir—hepatitis B	0.000554	0.0117	CcSEcCtD
Zalcitabine—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.00054	0.0115	CcSEcCtD
Zalcitabine—Myopathy—Telbivudine—hepatitis B	0.000526	0.0111	CcSEcCtD
Zalcitabine—Hepatomegaly—Telbivudine—hepatitis B	0.000521	0.011	CcSEcCtD
Zalcitabine—Influenza-like symptoms—Telbivudine—hepatitis B	0.000516	0.0109	CcSEcCtD
Zalcitabine—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00046	0.00975	CcSEcCtD
Zalcitabine—Rhinorrhoea—Telbivudine—hepatitis B	0.000455	0.00965	CcSEcCtD
Zalcitabine—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.000438	0.00929	CcSEcCtD
Zalcitabine—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.00043	0.00912	CcSEcCtD
Zalcitabine—Tenderness—Telbivudine—hepatitis B	0.000422	0.00896	CcSEcCtD
Zalcitabine—Chest discomfort—Telbivudine—hepatitis B	0.000417	0.00884	CcSEcCtD
Zalcitabine—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.000411	0.00871	CcSEcCtD
Zalcitabine—CYP3A43—liver—hepatitis B	0.000411	0.12	CbGeAlD
Zalcitabine—Cardiomyopathy—Lamivudine—hepatitis B	0.000406	0.00861	CcSEcCtD
Zalcitabine—Neck pain—Telbivudine—hepatitis B	0.000373	0.00791	CcSEcCtD
Zalcitabine—Suicide attempt—Lamivudine—hepatitis B	0.000366	0.00776	CcSEcCtD
Zalcitabine—Gingival bleeding—Lamivudine—hepatitis B	0.000366	0.00776	CcSEcCtD
Zalcitabine—Influenza like illness—Telbivudine—hepatitis B	0.000358	0.00759	CcSEcCtD
Zalcitabine—SLC29A2—blood—hepatitis B	0.000338	0.0993	CbGeAlD
Zalcitabine—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.000334	0.00708	CcSEcCtD
Zalcitabine—Blood creatinine increased—Entecavir—hepatitis B	0.000305	0.00647	CcSEcCtD
Zalcitabine—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.000298	0.00631	CcSEcCtD
Zalcitabine—Abdominal pain upper—Entecavir—hepatitis B	0.000297	0.00631	CcSEcCtD
Zalcitabine—Myopathy—Lamivudine—hepatitis B	0.000296	0.00628	CcSEcCtD
Zalcitabine—Hepatomegaly—Lamivudine—hepatitis B	0.000293	0.00622	CcSEcCtD
Zalcitabine—Throat sore—Lamivudine—hepatitis B	0.000288	0.00611	CcSEcCtD
Zalcitabine—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.000286	0.00606	CcSEcCtD
Zalcitabine—Renal impairment—Telbivudine—hepatitis B	0.000281	0.00596	CcSEcCtD
Zalcitabine—Pancreatitis—Entecavir—hepatitis B	0.000276	0.00585	CcSEcCtD
Zalcitabine—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.000269	0.00571	CcSEcCtD
Zalcitabine—Pain in extremity—Telbivudine—hepatitis B	0.000268	0.00568	CcSEcCtD
Zalcitabine—SLC29A2—liver—hepatitis B	0.000265	0.0776	CbGeAlD
Zalcitabine—Migraine—Telbivudine—hepatitis B	0.000263	0.00559	CcSEcCtD
Zalcitabine—Neutropenia—Entecavir—hepatitis B	0.000263	0.00558	CcSEcCtD
Zalcitabine—Rhinorrhoea—Lamivudine—hepatitis B	0.000256	0.00544	CcSEcCtD
Zalcitabine—Hyperglycaemia—Entecavir—hepatitis B	0.000254	0.00539	CcSEcCtD
Zalcitabine—Dysphonia—Lamivudine—hepatitis B	0.000252	0.00536	CcSEcCtD
Zalcitabine—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.000248	0.00527	CcSEcCtD
Zalcitabine—Abdominal pain upper—Telbivudine—hepatitis B	0.000244	0.00518	CcSEcCtD
Zalcitabine—Cramp muscle—Telbivudine—hepatitis B	0.000241	0.00511	CcSEcCtD
Zalcitabine—Nasopharyngitis—Telbivudine—hepatitis B	0.000239	0.00507	CcSEcCtD
Zalcitabine—Jaundice—Adefovir Dipivoxil—hepatitis B	0.000239	0.00506	CcSEcCtD
Zalcitabine—Gastritis—Telbivudine—hepatitis B	0.000237	0.00502	CcSEcCtD
Zalcitabine—Muscular weakness—Telbivudine—hepatitis B	0.000236	0.00501	CcSEcCtD
Zalcitabine—Abdominal distension—Telbivudine—hepatitis B	0.000233	0.00494	CcSEcCtD
Zalcitabine—Rectal haemorrhage—Lamivudine—hepatitis B	0.00023	0.00488	CcSEcCtD
Zalcitabine—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00023	0.00487	CcSEcCtD
Zalcitabine—Oropharyngeal pain—Lamivudine—hepatitis B	0.000228	0.00485	CcSEcCtD
Zalcitabine—CYP3A5—blood plasma—hepatitis B	0.000227	0.0665	CbGeAlD
Zalcitabine—Hepatitis—Entecavir—hepatitis B	0.000225	0.00478	CcSEcCtD
Zalcitabine—CYP2C9—blood plasma—hepatitis B	0.000223	0.0654	CbGeAlD
Zalcitabine—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00022	0.00466	CcSEcCtD
Zalcitabine—Hearing impaired—Lamivudine—hepatitis B	0.000218	0.00463	CcSEcCtD
Zalcitabine—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.000218	0.00463	CcSEcCtD
Zalcitabine—Neutropenia—Telbivudine—hepatitis B	0.000216	0.00459	CcSEcCtD
Zalcitabine—Inflammation—Lamivudine—hepatitis B	0.000214	0.00454	CcSEcCtD
Zalcitabine—Muscle twitching—Lamivudine—hepatitis B	0.000212	0.00449	CcSEcCtD
Zalcitabine—Eructation—Lamivudine—hepatitis B	0.000204	0.00433	CcSEcCtD
Zalcitabine—CYP3A43—Xenobiotics—CYP2A6—hepatitis B	0.000203	0.0704	CbGpPWpGaD
Zalcitabine—Neuropathy peripheral—Telbivudine—hepatitis B	0.000202	0.00429	CcSEcCtD
Zalcitabine—Wheezing—Lamivudine—hepatitis B	0.000202	0.00428	CcSEcCtD
Zalcitabine—Alopecia—Entecavir—hepatitis B	0.000199	0.00422	CcSEcCtD
Zalcitabine—Photophobia—Lamivudine—hepatitis B	0.000195	0.00414	CcSEcCtD
Zalcitabine—Flatulence—Adefovir Dipivoxil—hepatitis B	0.000189	0.004	CcSEcCtD
Zalcitabine—Urine output increased—Lamivudine—hepatitis B	0.000188	0.00398	CcSEcCtD
Zalcitabine—Back pain—Adefovir Dipivoxil—hepatitis B	0.000185	0.00393	CcSEcCtD
Zalcitabine—Hepatitis—Telbivudine—hepatitis B	0.000185	0.00393	CcSEcCtD
Zalcitabine—CYP3A7—liver—hepatitis B	0.000184	0.0541	CbGeAlD
Zalcitabine—Pharyngitis—Telbivudine—hepatitis B	0.000184	0.0039	CcSEcCtD
Zalcitabine—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000177	0.00375	CcSEcCtD
Zalcitabine—Lymphadenopathy—Lamivudine—hepatitis B	0.000177	0.00375	CcSEcCtD
Zalcitabine—Leukopenia—Entecavir—hepatitis B	0.000176	0.00372	CcSEcCtD
Zalcitabine—Polyuria—Lamivudine—hepatitis B	0.000172	0.00364	CcSEcCtD
Zalcitabine—CYP3A4—blood plasma—hepatitis B	0.00017	0.0499	CbGeAlD
Zalcitabine—SLC22A7—liver—hepatitis B	0.00017	0.0499	CbGeAlD
Zalcitabine—Deafness—Lamivudine—hepatitis B	0.000169	0.00358	CcSEcCtD
Zalcitabine—SLC29A1—blood—hepatitis B	0.000168	0.0492	CbGeAlD
Zalcitabine—CYP2D6—blood plasma—hepatitis B	0.000167	0.0491	CbGeAlD
Zalcitabine—Cough—Adefovir Dipivoxil—hepatitis B	0.000167	0.00354	CcSEcCtD
Zalcitabine—SLC29A1—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000164	0.0569	CbGpPWpGaD
Zalcitabine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.000163	0.00346	CcSEcCtD
Zalcitabine—DCK—blood—hepatitis B	0.00016	0.047	CbGeAlD
Zalcitabine—Infection—Entecavir—hepatitis B	0.000159	0.00337	CcSEcCtD
Zalcitabine—Renal impairment—Lamivudine—hepatitis B	0.000158	0.00336	CcSEcCtD
Zalcitabine—Dysgeusia—Telbivudine—hepatitis B	0.000158	0.00335	CcSEcCtD
Zalcitabine—CYP3A7-CYP3A51P—liver—hepatitis B	0.000157	0.046	CbGeAlD
Zalcitabine—Back pain—Telbivudine—hepatitis B	0.000156	0.00331	CcSEcCtD
Zalcitabine—Skin disorder—Entecavir—hepatitis B	0.000155	0.0033	CcSEcCtD
Zalcitabine—Muscle spasms—Telbivudine—hepatitis B	0.000155	0.00329	CcSEcCtD
Zalcitabine—Hypoglycaemia—Lamivudine—hepatitis B	0.000154	0.00328	CcSEcCtD
Zalcitabine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.000153	0.00324	CcSEcCtD
Zalcitabine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000152	0.00322	CcSEcCtD
Zalcitabine—Ill-defined disorder—Telbivudine—hepatitis B	0.000149	0.00317	CcSEcCtD
Zalcitabine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.000149	0.00316	CcSEcCtD
Zalcitabine—Affect lability—Lamivudine—hepatitis B	0.000148	0.00315	CcSEcCtD
Zalcitabine—Migraine—Lamivudine—hepatitis B	0.000148	0.00315	CcSEcCtD
Zalcitabine—Malaise—Telbivudine—hepatitis B	0.000145	0.00308	CcSEcCtD
Zalcitabine—Insomnia—Entecavir—hepatitis B	0.000145	0.00307	CcSEcCtD
Zalcitabine—Mood swings—Lamivudine—hepatitis B	0.000143	0.00303	CcSEcCtD
Zalcitabine—Somnolence—Entecavir—hepatitis B	0.000142	0.00302	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000142	0.00302	CcSEcCtD
Zalcitabine—Dyspepsia—Entecavir—hepatitis B	0.000141	0.00299	CcSEcCtD
Zalcitabine—Cough—Telbivudine—hepatitis B	0.000141	0.00298	CcSEcCtD
Zalcitabine—Fatigue—Entecavir—hepatitis B	0.000138	0.00293	CcSEcCtD
Zalcitabine—Abdominal pain upper—Lamivudine—hepatitis B	0.000138	0.00292	CcSEcCtD
Zalcitabine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.000137	0.00292	CcSEcCtD
Zalcitabine—Arthralgia—Telbivudine—hepatitis B	0.000137	0.00291	CcSEcCtD
Zalcitabine—Myalgia—Telbivudine—hepatitis B	0.000137	0.00291	CcSEcCtD
Zalcitabine—Cramp muscle—Lamivudine—hepatitis B	0.000136	0.00288	CcSEcCtD
Zalcitabine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000136	0.00288	CcSEcCtD
Zalcitabine—Discomfort—Telbivudine—hepatitis B	0.000136	0.00287	CcSEcCtD
Zalcitabine—Nasopharyngitis—Lamivudine—hepatitis B	0.000135	0.00286	CcSEcCtD
Zalcitabine—Muscular weakness—Lamivudine—hepatitis B	0.000133	0.00282	CcSEcCtD
Zalcitabine—Abdominal distension—Lamivudine—hepatitis B	0.000131	0.00278	CcSEcCtD
Zalcitabine—SLC29A1—liver—hepatitis B	0.000131	0.0385	CbGeAlD
Zalcitabine—Gastrointestinal pain—Entecavir—hepatitis B	0.000131	0.00278	CcSEcCtD
Zalcitabine—Dysphagia—Lamivudine—hepatitis B	0.00013	0.00276	CcSEcCtD
Zalcitabine—Thrombocytopenia—Telbivudine—hepatitis B	0.000129	0.00273	CcSEcCtD
Zalcitabine—Pancreatitis—Lamivudine—hepatitis B	0.000128	0.00271	CcSEcCtD
Zalcitabine—Skin disorder—Telbivudine—hepatitis B	0.000128	0.00271	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.000128	0.00271	CcSEcCtD
Zalcitabine—Sweating increased—Lamivudine—hepatitis B	0.000127	0.00269	CcSEcCtD
Zalcitabine—Body temperature increased—Entecavir—hepatitis B	0.000127	0.00268	CcSEcCtD
Zalcitabine—Abdominal pain—Entecavir—hepatitis B	0.000127	0.00268	CcSEcCtD
Zalcitabine—DCK—liver—hepatitis B	0.000125	0.0368	CbGeAlD
Zalcitabine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000123	0.00262	CcSEcCtD
Zalcitabine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000123	0.00262	CcSEcCtD
Zalcitabine—Dysuria—Lamivudine—hepatitis B	0.000122	0.00258	CcSEcCtD
Zalcitabine—Neutropenia—Lamivudine—hepatitis B	0.000122	0.00258	CcSEcCtD
Zalcitabine—Pollakiuria—Lamivudine—hepatitis B	0.00012	0.00255	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00012	0.00254	CcSEcCtD
Zalcitabine—Insomnia—Telbivudine—hepatitis B	0.000119	0.00252	CcSEcCtD
Zalcitabine—Hyperglycaemia—Lamivudine—hepatitis B	0.000118	0.00249	CcSEcCtD
Zalcitabine—Depression—Lamivudine—hepatitis B	0.000116	0.00246	CcSEcCtD
Zalcitabine—Dyspepsia—Telbivudine—hepatitis B	0.000116	0.00246	CcSEcCtD
Zalcitabine—Asthenia—Entecavir—hepatitis B	0.000115	0.00244	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Lamivudine—hepatitis B	0.000114	0.00242	CcSEcCtD
Zalcitabine—Fatigue—Telbivudine—hepatitis B	0.000113	0.0024	CcSEcCtD
Zalcitabine—Jaundice—Lamivudine—hepatitis B	0.000113	0.0024	CcSEcCtD
Zalcitabine—Pain—Telbivudine—hepatitis B	0.000112	0.00239	CcSEcCtD
Zalcitabine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000112	0.00238	CcSEcCtD
Zalcitabine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00011	0.00234	CcSEcCtD
Zalcitabine—Epistaxis—Lamivudine—hepatitis B	0.00011	0.00232	CcSEcCtD
Zalcitabine—Diarrhoea—Entecavir—hepatitis B	0.00011	0.00232	CcSEcCtD
Zalcitabine—Sinusitis—Lamivudine—hepatitis B	0.000109	0.00231	CcSEcCtD
Zalcitabine—Feeling abnormal—Telbivudine—hepatitis B	0.000108	0.0023	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Telbivudine—hepatitis B	0.000108	0.00228	CcSEcCtD
Zalcitabine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000107	0.00227	CcSEcCtD
Zalcitabine—Dizziness—Entecavir—hepatitis B	0.000106	0.00225	CcSEcCtD
Zalcitabine—Rhinitis—Lamivudine—hepatitis B	0.000105	0.00222	CcSEcCtD
Zalcitabine—Hepatitis—Lamivudine—hepatitis B	0.000104	0.00221	CcSEcCtD
Zalcitabine—Abdominal pain—Telbivudine—hepatitis B	0.000104	0.0022	CcSEcCtD
Zalcitabine—Body temperature increased—Telbivudine—hepatitis B	0.000104	0.0022	CcSEcCtD
Zalcitabine—Pharyngitis—Lamivudine—hepatitis B	0.000104	0.0022	CcSEcCtD
Zalcitabine—Vomiting—Entecavir—hepatitis B	0.000102	0.00216	CcSEcCtD
Zalcitabine—CYP3A5—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.000102	0.0352	CbGpPWpGaD
Zalcitabine—Rash—Entecavir—hepatitis B	0.000101	0.00214	CcSEcCtD
Zalcitabine—Dermatitis—Entecavir—hepatitis B	0.000101	0.00214	CcSEcCtD
Zalcitabine—Headache—Entecavir—hepatitis B	0.0001	0.00213	CcSEcCtD
Zalcitabine—Vomiting—Adefovir Dipivoxil—hepatitis B	9.93e-05	0.00211	CcSEcCtD
Zalcitabine—Rash—Adefovir Dipivoxil—hepatitis B	9.85e-05	0.00209	CcSEcCtD
Zalcitabine—Dermatitis—Adefovir Dipivoxil—hepatitis B	9.84e-05	0.00209	CcSEcCtD
Zalcitabine—Headache—Adefovir Dipivoxil—hepatitis B	9.78e-05	0.00208	CcSEcCtD
Zalcitabine—Asthenia—Telbivudine—hepatitis B	9.43e-05	0.002	CcSEcCtD
Zalcitabine—SLC22A7—Fluoropyrimidine Activity—CYP2A6—hepatitis B	9.36e-05	0.0324	CbGpPWpGaD
Zalcitabine—Chills—Lamivudine—hepatitis B	9.36e-05	0.00199	CcSEcCtD
Zalcitabine—Pruritus—Telbivudine—hepatitis B	9.3e-05	0.00197	CcSEcCtD
Zalcitabine—Alopecia—Lamivudine—hepatitis B	9.22e-05	0.00196	CcSEcCtD
Zalcitabine—Diarrhoea—Telbivudine—hepatitis B	9e-05	0.00191	CcSEcCtD
Zalcitabine—Flatulence—Lamivudine—hepatitis B	8.95e-05	0.0019	CcSEcCtD
Zalcitabine—Tension—Lamivudine—hepatitis B	8.91e-05	0.00189	CcSEcCtD
Zalcitabine—Dysgeusia—Lamivudine—hepatitis B	8.89e-05	0.00189	CcSEcCtD
Zalcitabine—Nervousness—Lamivudine—hepatitis B	8.82e-05	0.00187	CcSEcCtD
Zalcitabine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	8.79e-05	0.0304	CbGpPWpGaD
Zalcitabine—Back pain—Lamivudine—hepatitis B	8.78e-05	0.00186	CcSEcCtD
Zalcitabine—Muscle spasms—Lamivudine—hepatitis B	8.73e-05	0.00185	CcSEcCtD
Zalcitabine—Dizziness—Telbivudine—hepatitis B	8.7e-05	0.00184	CcSEcCtD
Zalcitabine—Tremor—Lamivudine—hepatitis B	8.51e-05	0.0018	CcSEcCtD
Zalcitabine—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	8.44e-05	0.0292	CbGpPWpGaD
Zalcitabine—Ill-defined disorder—Lamivudine—hepatitis B	8.42e-05	0.00179	CcSEcCtD
Zalcitabine—Anaemia—Lamivudine—hepatitis B	8.39e-05	0.00178	CcSEcCtD
Zalcitabine—Vomiting—Telbivudine—hepatitis B	8.36e-05	0.00177	CcSEcCtD
Zalcitabine—CYP3A43—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	8.33e-05	0.0288	CbGpPWpGaD
Zalcitabine—CYP3A5—blood—hepatitis B	8.3e-05	0.0243	CbGeAlD
Zalcitabine—Rash—Telbivudine—hepatitis B	8.29e-05	0.00176	CcSEcCtD
Zalcitabine—Dermatitis—Telbivudine—hepatitis B	8.28e-05	0.00176	CcSEcCtD
Zalcitabine—Headache—Telbivudine—hepatitis B	8.24e-05	0.00175	CcSEcCtD
Zalcitabine—Malaise—Lamivudine—hepatitis B	8.19e-05	0.00174	CcSEcCtD
Zalcitabine—CYP3A7—Xenobiotics—CYP2A6—hepatitis B	8.18e-05	0.0283	CbGpPWpGaD
Zalcitabine—CYP2C9—blood—hepatitis B	8.17e-05	0.024	CbGeAlD
Zalcitabine—Vertigo—Lamivudine—hepatitis B	8.16e-05	0.00173	CcSEcCtD
Zalcitabine—Syncope—Lamivudine—hepatitis B	8.14e-05	0.00173	CcSEcCtD
Zalcitabine—Leukopenia—Lamivudine—hepatitis B	8.13e-05	0.00172	CcSEcCtD
Zalcitabine—Loss of consciousness—Lamivudine—hepatitis B	7.98e-05	0.00169	CcSEcCtD
Zalcitabine—Cough—Lamivudine—hepatitis B	7.92e-05	0.00168	CcSEcCtD
Zalcitabine—Convulsion—Lamivudine—hepatitis B	7.87e-05	0.00167	CcSEcCtD
Zalcitabine—Arthralgia—Lamivudine—hepatitis B	7.73e-05	0.00164	CcSEcCtD
Zalcitabine—Myalgia—Lamivudine—hepatitis B	7.73e-05	0.00164	CcSEcCtD
Zalcitabine—Anxiety—Lamivudine—hepatitis B	7.7e-05	0.00163	CcSEcCtD
Zalcitabine—Discomfort—Lamivudine—hepatitis B	7.64e-05	0.00162	CcSEcCtD
Zalcitabine—Dry mouth—Lamivudine—hepatitis B	7.56e-05	0.0016	CcSEcCtD
Zalcitabine—Confusional state—Lamivudine—hepatitis B	7.47e-05	0.00158	CcSEcCtD
Zalcitabine—Oedema—Lamivudine—hepatitis B	7.41e-05	0.00157	CcSEcCtD
Zalcitabine—Infection—Lamivudine—hepatitis B	7.36e-05	0.00156	CcSEcCtD
Zalcitabine—Shock—Lamivudine—hepatitis B	7.29e-05	0.00155	CcSEcCtD
Zalcitabine—Thrombocytopenia—Lamivudine—hepatitis B	7.26e-05	0.00154	CcSEcCtD
Zalcitabine—Skin disorder—Lamivudine—hepatitis B	7.2e-05	0.00153	CcSEcCtD
Zalcitabine—Hyperhidrosis—Lamivudine—hepatitis B	7.16e-05	0.00152	CcSEcCtD
Zalcitabine—Anorexia—Lamivudine—hepatitis B	7.06e-05	0.0015	CcSEcCtD
Zalcitabine—CYP3A43—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	6.84e-05	0.0237	CbGpPWpGaD
Zalcitabine—CYP2D6—CYP2E1 reactions—CYP2A6—hepatitis B	6.79e-05	0.0235	CbGpPWpGaD
Zalcitabine—Musculoskeletal discomfort—Lamivudine—hepatitis B	6.75e-05	0.00143	CcSEcCtD
Zalcitabine—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	6.73e-05	0.0233	CbGpPWpGaD
Zalcitabine—Insomnia—Lamivudine—hepatitis B	6.7e-05	0.00142	CcSEcCtD
Zalcitabine—Dyspnoea—Lamivudine—hepatitis B	6.61e-05	0.0014	CcSEcCtD
Zalcitabine—Somnolence—Lamivudine—hepatitis B	6.59e-05	0.0014	CcSEcCtD
Zalcitabine—Dyspepsia—Lamivudine—hepatitis B	6.52e-05	0.00138	CcSEcCtD
Zalcitabine—CYP3A5—liver—hepatitis B	6.49e-05	0.019	CbGeAlD
Zalcitabine—Decreased appetite—Lamivudine—hepatitis B	6.44e-05	0.00137	CcSEcCtD
Zalcitabine—Fatigue—Lamivudine—hepatitis B	6.39e-05	0.00136	CcSEcCtD
Zalcitabine—CYP2C9—liver—hepatitis B	6.39e-05	0.0187	CbGeAlD
Zalcitabine—Pain—Lamivudine—hepatitis B	6.34e-05	0.00134	CcSEcCtD
Zalcitabine—CYP3A4—blood—hepatitis B	6.23e-05	0.0183	CbGeAlD
Zalcitabine—CYP3A43—Metapathway biotransformation—AKR1B1—hepatitis B	6.17e-05	0.0214	CbGpPWpGaD
Zalcitabine—CYP2D6—blood—hepatitis B	6.13e-05	0.018	CbGeAlD
Zalcitabine—Feeling abnormal—Lamivudine—hepatitis B	6.11e-05	0.0013	CcSEcCtD
Zalcitabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	6.09e-05	0.0211	CbGpPWpGaD
Zalcitabine—Gastrointestinal pain—Lamivudine—hepatitis B	6.06e-05	0.00129	CcSEcCtD
Zalcitabine—CYP3A43—Biological oxidations—GGT2—hepatitis B	6e-05	0.0208	CbGpPWpGaD
Zalcitabine—CYP3A5—Xenobiotics—CYP2A6—hepatitis B	5.92e-05	0.0205	CbGpPWpGaD
Zalcitabine—Urticaria—Lamivudine—hepatitis B	5.89e-05	0.00125	CcSEcCtD
Zalcitabine—Abdominal pain—Lamivudine—hepatitis B	5.86e-05	0.00124	CcSEcCtD
Zalcitabine—Body temperature increased—Lamivudine—hepatitis B	5.86e-05	0.00124	CcSEcCtD
Zalcitabine—CYP3A5—Tamoxifen metabolism—CYP2A6—hepatitis B	5.69e-05	0.0197	CbGpPWpGaD
Zalcitabine—Hypersensitivity—Lamivudine—hepatitis B	5.46e-05	0.00116	CcSEcCtD
Zalcitabine—Asthenia—Lamivudine—hepatitis B	5.32e-05	0.00113	CcSEcCtD
Zalcitabine—Pruritus—Lamivudine—hepatitis B	5.24e-05	0.00111	CcSEcCtD
Zalcitabine—Diarrhoea—Lamivudine—hepatitis B	5.07e-05	0.00108	CcSEcCtD
Zalcitabine—CYP2D6—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	5.03e-05	0.0174	CbGpPWpGaD
Zalcitabine—Dizziness—Lamivudine—hepatitis B	4.9e-05	0.00104	CcSEcCtD
Zalcitabine—CYP3A4—liver—hepatitis B	4.87e-05	0.0143	CbGeAlD
Zalcitabine—CYP3A5—Aflatoxin activation and detoxification—GGT1—hepatitis B	4.81e-05	0.0167	CbGpPWpGaD
Zalcitabine—CYP2D6—liver—hepatitis B	4.79e-05	0.0141	CbGeAlD
Zalcitabine—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	4.73e-05	0.0164	CbGpPWpGaD
Zalcitabine—Vomiting—Lamivudine—hepatitis B	4.71e-05	0.000999	CcSEcCtD
Zalcitabine—Rash—Lamivudine—hepatitis B	4.67e-05	0.000991	CcSEcCtD
Zalcitabine—Dermatitis—Lamivudine—hepatitis B	4.67e-05	0.00099	CcSEcCtD
Zalcitabine—Headache—Lamivudine—hepatitis B	4.64e-05	0.000985	CcSEcCtD
Zalcitabine—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	4.4e-05	0.0152	CbGpPWpGaD
Zalcitabine—CYP2D6—Xenobiotics—CYP2A6—hepatitis B	4.21e-05	0.0146	CbGpPWpGaD
Zalcitabine—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	4.17e-05	0.0144	CbGpPWpGaD
Zalcitabine—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	4.06e-05	0.0141	CbGpPWpGaD
Zalcitabine—CYP2D6—Tamoxifen metabolism—CYP2A6—hepatitis B	4.05e-05	0.014	CbGpPWpGaD
Zalcitabine—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	4.01e-05	0.0139	CbGpPWpGaD
Zalcitabine—CYP3A43—Biological oxidations—CYP2A6—hepatitis B	3.63e-05	0.0126	CbGpPWpGaD
Zalcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—hepatitis B	3.55e-05	0.0123	CbGpPWpGaD
Zalcitabine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	3.4e-05	0.0118	CbGpPWpGaD
Zalcitabine—CYP3A7—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	3.35e-05	0.0116	CbGpPWpGaD
Zalcitabine—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	3.29e-05	0.0114	CbGpPWpGaD
Zalcitabine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	2.86e-05	0.00991	CbGpPWpGaD
Zalcitabine—CYP3A43—Biological oxidations—GGT1—hepatitis B	2.84e-05	0.00982	CbGpPWpGaD
Zalcitabine—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	2.75e-05	0.00954	CbGpPWpGaD
Zalcitabine—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	2.75e-05	0.00952	CbGpPWpGaD
Zalcitabine—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	2.65e-05	0.00916	CbGpPWpGaD
Zalcitabine—CYP3A7—Metapathway biotransformation—AKR1B1—hepatitis B	2.48e-05	0.0086	CbGpPWpGaD
Zalcitabine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	2.46e-05	0.00851	CbGpPWpGaD
Zalcitabine—CYP3A5—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	2.42e-05	0.00839	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—GGT2—hepatitis B	2.42e-05	0.00836	CbGpPWpGaD
Zalcitabine—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	2.24e-05	0.00775	CbGpPWpGaD
Zalcitabine—SLC22A7—Fluoropyrimidine Activity—TP53—hepatitis B	2.02e-05	0.00701	CbGpPWpGaD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	2.02e-05	0.007	CbGpPWpGaD
Zalcitabine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	1.99e-05	0.0069	CbGpPWpGaD
Zalcitabine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	1.89e-05	0.00654	CbGpPWpGaD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—ALB—hepatitis B	1.89e-05	0.00654	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—AKR1B1—hepatitis B	1.8e-05	0.00622	CbGpPWpGaD
Zalcitabine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	1.75e-05	0.00605	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—GGT2—hepatitis B	1.75e-05	0.00605	CbGpPWpGaD
Zalcitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	1.73e-05	0.006	CbGpPWpGaD
Zalcitabine—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	1.72e-05	0.00597	CbGpPWpGaD
Zalcitabine—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	1.71e-05	0.00592	CbGpPWpGaD
Zalcitabine—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	1.56e-05	0.00542	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—CYP2A6—hepatitis B	1.46e-05	0.00507	CbGpPWpGaD
Zalcitabine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	1.42e-05	0.0049	CbGpPWpGaD
Zalcitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	1.4e-05	0.00486	CbGpPWpGaD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	1.38e-05	0.00476	CbGpPWpGaD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—ALB—hepatitis B	1.31e-05	0.00453	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	1.28e-05	0.00442	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	1.27e-05	0.00438	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GGT2—hepatitis B	1.24e-05	0.0043	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GGT2—hepatitis B	1.23e-05	0.00426	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—GGT1—hepatitis B	1.14e-05	0.00396	CbGpPWpGaD
Zalcitabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	1.14e-05	0.00395	CbGpPWpGaD
Zalcitabine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	1.13e-05	0.0039	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AKR1B1—hepatitis B	1.09e-05	0.00376	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AKR1B1—hepatitis B	1.07e-05	0.0037	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—CYP2A6—hepatitis B	1.06e-05	0.00366	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GGT2—hepatitis B	1.04e-05	0.00361	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GGT2—hepatitis B	1.03e-05	0.00355	CbGpPWpGaD
Zalcitabine—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	9.85e-06	0.00341	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—ALB—hepatitis B	9.59e-06	0.00332	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	9.26e-06	0.00321	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	8.35e-06	0.00289	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—GGT1—hepatitis B	8.26e-06	0.00286	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GGT2—hepatitis B	8.12e-06	0.00281	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	7.52e-06	0.0026	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	7.46e-06	0.00258	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—ALB—hepatitis B	7.45e-06	0.00258	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—ALB—hepatitis B	6.65e-06	0.0023	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP2A6—hepatitis B	6.31e-06	0.00218	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP2A6—hepatitis B	6.21e-06	0.00215	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GGT1—hepatitis B	5.87e-06	0.00203	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GGT1—hepatitis B	5.82e-06	0.00202	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GOT2—hepatitis B	5.71e-06	0.00198	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GOT2—hepatitis B	5.62e-06	0.00195	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—ALB—hepatitis B	5.23e-06	0.00181	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	4.93e-06	0.00171	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GGT1—hepatitis B	4.93e-06	0.00171	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GOT1—hepatitis B	4.93e-06	0.00171	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	4.92e-06	0.0017	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GOT1—hepatitis B	4.85e-06	0.00168	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GGT1—hepatitis B	4.85e-06	0.00168	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKR1B1—hepatitis B	4.31e-06	0.00149	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GGT2—hepatitis B	4.13e-06	0.00143	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GGT1—hepatitis B	3.84e-06	0.00133	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ALB—hepatitis B	3.79e-06	0.00131	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKR1B1—hepatitis B	3.11e-06	0.00108	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GGT2—hepatitis B	2.99e-06	0.00103	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ALB—hepatitis B	2.66e-06	0.00092	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ALB—hepatitis B	2.62e-06	0.000907	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ALB—hepatitis B	2.58e-06	0.000893	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP2A6—hepatitis B	2.5e-06	0.000867	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GOT2—hepatitis B	2.26e-06	0.000784	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.24e-06	0.000774	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKR1B1—hepatitis B	2.21e-06	0.000767	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKR1B1—hepatitis B	2.2e-06	0.00076	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GGT2—hepatitis B	2.12e-06	0.000735	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GGT2—hepatitis B	2.1e-06	0.000729	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTEN—hepatitis B	2e-06	0.000692	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTEN—hepatitis B	1.97e-06	0.000682	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GGT1—hepatitis B	1.95e-06	0.000676	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GOT1—hepatitis B	1.95e-06	0.000676	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2A6—hepatitis B	1.81e-06	0.000626	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GOT2—hepatitis B	1.64e-06	0.000566	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKR1B1—hepatitis B	1.45e-06	0.000501	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GGT1—hepatitis B	1.41e-06	0.000489	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GOT1—hepatitis B	1.41e-06	0.000489	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GGT2—hepatitis B	1.39e-06	0.000481	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2A6—hepatitis B	1.29e-06	0.000445	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2A6—hepatitis B	1.28e-06	0.000442	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.19e-06	0.000412	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GOT2—hepatitis B	1.16e-06	0.000403	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GOT2—hepatitis B	1.15e-06	0.000399	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALB—hepatitis B	1.04e-06	0.00036	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GGT1—hepatitis B	1e-06	0.000348	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GOT1—hepatitis B	1e-06	0.000348	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GOT1—hepatitis B	9.96e-07	0.000345	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GGT1—hepatitis B	9.96e-07	0.000345	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	9.07e-07	0.000314	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2A6—hepatitis B	8.41e-07	0.000291	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTEN—hepatitis B	7.93e-07	0.000275	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GOT2—hepatitis B	7.61e-07	0.000263	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALB—hepatitis B	7.51e-07	0.00026	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GOT1—hepatitis B	6.57e-07	0.000227	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GGT1—hepatitis B	6.57e-07	0.000227	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTEN—hepatitis B	5.73e-07	0.000198	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALB—hepatitis B	5.34e-07	0.000185	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALB—hepatitis B	5.3e-07	0.000183	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTEN—hepatitis B	4.08e-07	0.000141	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTEN—hepatitis B	4.04e-07	0.00014	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALB—hepatitis B	3.49e-07	0.000121	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTEN—hepatitis B	2.66e-07	9.23e-05	CbGpPWpGaD
